Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).

Pulm Circ · 2019 · PMC6540507 · PMID 30957635

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

4 , 9 , 10 In conclusion, the preliminary signals from AMBER I suggest an encouraging trend towards an efficacy of ambrisentan in the treatment of CTEPH; however, this should be considered inconclusive due to the limited sample size.

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.